Dario Rusciano
Overview
Explore the profile of Dario Rusciano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
794
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rusciano D
Medicina (Kaunas)
. 2025 Jan;
60(12.
PMID: 39768839
This review highlights the therapeutic potential of epigallocatechin gallate (EGCG) and forskolin in managing retinal diseases, with a focus on glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy. EGCG, a...
2.
Rusciano D, Bagnoli P
Front Biosci (Landmark Ed)
. 2024 Sep;
29(9):319.
PMID: 39344319
Oxidative stress, caused by the formation of free radicals, such as reactive oxygen species (ROS), leads to cell and tissue degradation, contributing to various diseases and aging. While oxygen is...
3.
Gagliano C, Salvetat M, Musa M, DEsposito F, Rusciano D, Maniaci A, et al.
Front Biosci (Landmark Ed)
. 2024 Aug;
29(8):310.
PMID: 39206909
This review explores the connection between the ocular surface microbiome and glaucoma, highlighting its impact on disease progression. Beginning with an overview of global glaucoma significance, it emphasizes the importance...
4.
Rusciano D
Pharmaceuticals (Basel)
. 2024 May;
17(5).
PMID: 38794193
Gabapentin (GBP) was originally developed as a potential agonist for Gamma-Amino-Butyric-Acid (GABA) receptors, aiming to inhibit the activation of pain-signaling neurons. Contrary to initial expectations, it does not bind to...
5.
Rusciano D, Russo C
Pharmaceuticals (Basel)
. 2024 Apr;
17(4).
PMID: 38675402
Melatonin is a ubiquitous molecule found in living organisms, ranging from bacteria to plants and mammals. It possesses various properties, partly due to its robust antioxidant nature and partly owed...
6.
Russo C, Rusciano D, Santangelo R, Malaguarnera L
Medicina (Kaunas)
. 2024 Mar;
60(3).
PMID: 38541080
Antioxidants, usually administered orally through the systemic route, are known to counteract the harmful effects of oxidative stress on retinal cells. The formulation of these antioxidants as eye drops might...
7.
Caporarello N, Olivieri M, Cristaldi M, Rusciano D, Lupo G, Anfuso C
Int J Mol Med
. 2023 Sep;
52(5).
PMID: 37772381
Following the publication of the above article, an interested reader drew to the authors' attention that, in Fig. 7 on p. 1282, a pair of the western blotting bands in...
8.
Melecchi A, Amato R, Dal Monte M, Rusciano D, Bagnoli P, Cammalleri M
Front Med (Lausanne)
. 2023 Sep;
10:1230941.
PMID: 37731716
Introduction: Much interest has been addressed to antioxidant dietary supplements that are known to lower the risk of developing glaucoma or delay its progression. Among them, niacin and citicoline protect...
9.
Rusciano D, Bagnoli P
Medicina (Kaunas)
. 2023 Jul;
59(7).
PMID: 37512145
In this review, we aim to provide an overview of the recent findings about the treatment of neovascular retinal diseases. The use of conventional drugs and nutraceuticals endowed with antioxidant...
10.
Minnelli C, Piva F, Cecati M, Armeni T, Mobbili G, Galeazzi R, et al.
Pharmaceuticals (Basel)
. 2023 Apr;
16(4).
PMID: 37111351
Meldonium (MID) is a synthetic drug designed to decrease the availability of L-carnitine-a main player in mitochondrial energy generation-thus modulating the cell pathways of energy metabolism. Its clinical effects are...